유럽 ​​기관지확장증 시장 – 2028년까지의 산업 동향 및 예측

보고서 사용자 지정 보고서 사용자 지정 지금 구매 지금 구매 무료 샘플 보고서 무료 샘플 보고서
집 Pharmaceutical Europe Bronchiectasis Market
TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​기관지확장증 시장 – 2028년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Mar 2021
  • Europe
  • 350 Pages
  • 테이블 수: 440
  • 그림 수: 56
지금 구매 지금 구매

유럽 ​​기관지확장증 시장, 질병 유형별(CF 기관지확장증 및 비CF 기관지확장증), 심각도(경미~중등도 및 중등도~중증), 유형(진단 및 치료), 약물 유형(브랜드 및 제네릭), 투여 경로(경구, 비경구 및 흡입), 최종 사용자(병원, 진료소, 가정 의료 및 기타), 유통 채널(병원 약국, 소매 약국, 온라인 약국, 기타), 국가(독일, 영국, 프랑스, ​​이탈리아, 스페인, 네덜란드, 러시아, 스위스, 벨기에, 터키, 오스트리아, 노르웨이, 헝가리, 리투아니아, 아일랜드, 폴란드, 유럽의 나머지 지역) 산업 동향 및 2028년까지의 예측

유럽 ​​기관지확장증 시장시장 분석 및 통찰력: 유럽 기관지확장증 시장

기관지확장증 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 5.6%의 CAGR로 성장하고 있으며 2028년까지 2억 5,046만 달러에 도달할 것으로 예상한다고 분석합니다. 알코올 소비자와 흡연자의 증가와 질병 검사를 위한 기술의 발전은 예측 기간 동안 기관지확장증 시장 수요를 촉진한 주요 원동력입니다.

기관지확장증은 기도를 의미하는 그리스어 단어 bronckos에서 유래한 용어 이고 확장증은 확장을 의미합니다. 기관지의 비정상적이고 돌이킬 수 없는 확장으로 정의되는 만성 폐 질환으로, 근육 조직과 탄력 조직이 단기 및 장기 감염으로 인해 파괴됩니다. 이러한 감염이 합쳐지면 한쪽 또는 양쪽 폐가 손상됩니다. 손상 부위는 고해상도 컴퓨터 단층 촬영(HRCT) 스캔으로 진단하는데, 이를 통해 큰 기도가 대부분 영향을 받고 작은 기도는 스캔되지 않기 때문에 일부 환자는 진단 전 수년 동안 증상을 겪습니다.

기관지확장증 진단 및 치료는 중환자가 건강한 삶을 살 수 있도록 돕고, 환자가 생명을 구할 수 있도록 합니다. 이것이 기관지확장증으로 고통받는 환자 수가 증가하는 이유이며, 기관지확장증 시장 성장을 견인하는 원동력으로 작용하고 있습니다. 진단 도구의 높은 비용은 기관지확장증 시장 수요를 저해하는 제약으로 작용하고 있습니다. 기관지확장증에 대한 인식 프로그램의 증가는 전 세계의 조직과 사람들이 기관지확장증의 확산을 최소화하기 위해 취한 조치 중 하나입니다. 이러한 인식 프로그램은 기관지확장증 시장 성장의 기회로 작용할 수 있습니다. 기관지확장증 치료 중 합병증은 의료 서비스 제공자에게 도전이 되어 기관지확장증 시장 성장에 도전이 될 수 있습니다.

The bronchiectasis market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the bronchiectasis market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

유럽 ​​기관지확장증 시장Bronchiectasis Market Scope and Market Size

The bronchiectasis market is segmented on the basis of the disease type, severity, type, drugs type, route of administration, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of disease type, the bronchiectasis market is segmented into CF bronchiectasis and non-CF bronchiectasis. In 2021, non-CF bronchiectasis segment is expected to dominate the bronchiectasis market as it co-exists with other respiratory conditions such as chronic obstructive pulmonary disease (COPD) and is highly prevalent among women and geriatric population.
  • On the basis of severity, the bronchiectasis market is segmented into mild to moderate and moderate-to-severe. In 2021, mild to moderate segment is expected to dominate the bronchiectasis market because bronchiectasis is a progressive and chronic respiratory disorder which is characterized by persistent cough, abnormally dilated airways, excessive sputum production and recurrent pulmonary infections and all these symptoms are lifelong severe conditions.
  • On the basis of type, the bronchiectasis market is segmented into diagnosis and treatment. In 2021, treatment segment is expected to dominate the bronchiectasis market because patient diagnosed with bronchiectasis have to rely on effective and novel drug therapies so as to lead a normal healthy life.
  • On the basis of drugs type, the bronchiectasis market is segmented into branded and generics. In 2021, branded segment is expected to dominate the bronchiectasis market because drugs offered by the many companies are the patent formulation.
  • On the basis of route of administration, the bronchiectasis market is segmented into oral, parenteral and inhalation. In 2021, inhalation segment is expected to dominate the bronchiectasis market because inhalation route of administration offers effective drug delivery directly to lung airways and increasing technological advancement for launch of smart inhalers that allows patients to maintain accurate drug dosage is also providing market with lucrative growth.
  • On the basis of end user, the bronchiectasis market is segmented into hospitals, clinics, home healthcare and others. In 2021, hospitals segment is dominating the bronchiectasis market because hospitals provides with advanced diagnostic tools used for diagnosis of bronchiectasis associated symptoms.
  • On the basis of distribution channel, the bronchiectasis market is segmented into hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, hospital pharmacy segment is expected to dominate the bronchiectasis market as hospital pharmacy has wide range of products as per the patients need and demand.

Europe Bronchiectasis Market Country Level Analysis

Europe bronchiectasis market is analyzed and market size information is provided on the basis of the country, disease type, severity, type, drugs type, route of administration, end user and distribution channel as referenced above.

The countries covered in the Europe bronchiectasis market report are the Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Belgium, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe.

Non-CF bronchiectasis segment in Europe region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because non-cystic fibrosis bronchiectasis often coexists with other respiratory conditions such as chronic obstructive pulmonary disease. The prevalence of NCFB is increasing, particularly in women and older individuals. Germany is leading the growth of the Europe bronchiectasis market and non-CF bronchiectasis segment is dominating in the region due to rise in prevalence of respiratory diseases. France is the fastest growing country in the Europe region due to rising research and development. The U.K. holds the third largest market share in the European region because of rising government initiatives to create awareness related to the serious respiratory diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Diagnostic Rate and Increasing Healthcare Expenditure are boosting the Bronchiectasis Market Growth

기관지확장증 시장은 또한 기관지확장증 약물 판매, 기관지확장증 기술 발전의 영향, 기관지확장증 시장에 대한 지원과 함께 규제 시나리오의 변화와 함께 모든 국가 기관지확장증 산업의 성장에 대한 자세한 시장 분석을 제공합니다. 이 데이터는 2011년부터 2019년까지의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 기관지확장증 시장 점유율 분석

기관지확장증 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 있습니다. 제공된 위의 데이터 포인트는 기관지확장증 시장과 관련된 회사의 초점에만 관련이 있습니다.

유럽 ​​기관지확장증 시장 보고서에서 다루는 주요 기업으로는 Abbott, HERSILL, Indogen, Inc., Boehringer Ingelheim International GmbH, Medline Industries, Inc., Ache Laboratories Farmaceuticos SA, Horizon Therapeutics plc, Janssen Pharmaceuticals, Inc.(Johnson & Johnson Services, Inc.의 자회사), Trudell Medical International, GlaxoSmithKline plc, AstraZeneca, Pfizer Inc., Merck Sharp & Dohme Corp.(Merck & Co., Inc.의 자회사), Novartis AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Dr. Reddy's Laboratories Ltd., Sunovion Pharmaceuticals Inc.(Sumitomo Dainippon Pharma Co., Ltd.의 자회사), Viatris Inc., Covis Pharma, Cipla Inc. 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.

또한 전 세계 여러 회사에서 많은 제품 출시와 계약을 체결하면서 기관지확장증 시장이 활성화되고 있습니다.

예를 들어,

  • 2019년 6월, 아스트라제네카는 COPD 치료를 위해 일본에서 브레즈트리 에어로스피어(PT010)에 대한 승인을 받았습니다. 브레즈트리 에어로스피어는 부데소니드/글리코피로늄/포르모테롤 푸마르산염으로 구성되어 있으며 폐 염증 및 기타 만성 폐쇄성 질환을 앓고 있는 사람들에게 새로운 치료 선택으로 입증되었습니다. 이 승인은 회사가 전 세계 여러 지역에서 제품 판매를 확대하여 지속적인 매출을 올리는 데 도움이 되었습니다.

시장 참여자들의 협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 기타 전략은 기관지확장증 시장에서 회사 시장을 강화하고 있으며, 이를 통해 기업이 기관지확장증에 대한 제공 서비스를 개선하는 데 도움이 됩니다.

SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Sample Image Click on image to enlarge
  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE bronchiectasis MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. disease type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drugs type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Pipeline analysis
  5. Europe Bronchiectasis Market: Laws and regulations
  6. Epidemiology
  7. Market Overview
    1. Drivers
      1. Rising Patient Population Suffering from bronchiectasis
      2. growing geriatric population
      3. rising number of smokers and consumption of alcohol
      4. technological advancement for disease testing
      5. growing DIAGNOSTIC rate
    2. restrainTs
      1. high cost of diagnostic tools
      2. product recalls
      3. inappropriate reimbursement policies
    3. opportunities
      1. Rising awareness for prevention of bronchiectasis in primary and secondary care
      2. increasing healthcare expenditure
      3. increase in research regarding the bronchiectasis disease
      4. availability of generic drugs in underdeveloped and developing countries
    4. challenges
      1. complications in the treatment of bronchiectasis
      2. lack of skilled professionals
      3. diagnositic challenges
  8. IMPACT OF COVID-19
    1. PRICE IMPACT
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  9. europe bronchiectasis MARKET, BY disease type
    1. overview
    2. Non-CF Bronchiectasis
    3. CF Bronchiectasis
  10. europe bronchiectasis MARKET, BY severity
    1. overview
    2. mild to moderate
    3. moderate to severe
  11. europe bronchiectasis MARKET, BY type
    1. overview
    2. treatment
      1. Antibiotics
        1. MACROLIDE
          1. AZITHROMYCIN
          2. CLARITHROMYCIN
          3. OTHERS
        2. AMOXICILLIN
        3. CEPHALOSPORIN
          1. SECOND-GENERATION CEPHALOSPORIN
          2. THIRD-GENERATION CEPHALOSPORIN
        4. AMINOGLYCOSIDE
          1. GENTAMICIN
          2. TOBRAMYCIN
        5. FLUOROQUINOLONE
        6. TETRACYCLINS
        7. TRIMETHOPRIM-SULFAMETHOXAZOLE
        8. COMBINATION THERAPY
      2. Corticosteroids
        1. BUDESONIDE
        2. FLUTICASONE
        3. MOMETASONE
        4. FLUNISOLIDE
        5. OTHERS
      3. Bronchodilators
        1. LONG-ACTING BRONCHODILATORS
          1. FORMOTEROL
          2. TIOTROPIUM
          3. SALMETEROL
          4. OTHERS
        2. SHORT-ACTING BRONCHODILATORS
          1. ALBUTEROL
          2. LEVALBUTEROL
          3. OTHERS
      4. Mucus Thinning Medicine
        1. CARBOCISTEINE
        2. BROMHEXINE
        3. OTHERS
      5. Airway Clearance Devices
        1. OSCILLATING POSITIVE EXPIRATORY PRESSURE (PEP)
        2. INTRAPULMONARY PERCUSSIVE VENTILATION (IPV)
        3. POSTURAL DRAINAGE
        4. OTHERS
      6. Oxygen Therapy
        1. OXYGEN CONCENTRATORS
        2. COMPRESSED GAS OXYGEN
        3. LIQUID OXYGEN
      7. Surgery
        1. BRONCHOSCOPY
        2. LUNG TRANSPLANT
      8. Others
    3. diagnosis
      1. Chest CT Scan
      2. Sputum Test
      3. Pulmonary Function Test
      4. X-Ray
      5. Others
  12. europe bronchiectasis MARKET, BY drugs type
    1. overview
    2. branded
    3. generics
  13. europe bronchiectasis MARKET, BY route of administration
    1. overview
    2. inhalation
    3. oral
      1. Tablets
      2. Capsules
      3. Others
    4. parenteral
      1. Intravenous
      2. Subcutaneous
      3. Others
  14. europe bronchiectasis MARKET, BY end user
    1. overview
    2. hospitals
    3. clinics
    4. home healthcare
    5. others
  15. europe bronchiectasis MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online pharmacy
    5. others
  16. Europe Bronchiectasis Market by geography
    1. Overview
    2. EUROPE
      1. germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. NETHERLANDS
      7. Russia
      8. Switzerland
      9. Belgium
      10. Turkey
      11. Austria
      12. Norway
      13. Hungary
      14. Lithuania
      15. Ireland
      16. Poland
      17. Rest of Europe
  17. Europe Bronchiectasis Market: COMPANY landscape
    1. company share analysis: europe
  18. SWOT
  19. Company profiles
    1. AstraZeneca
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. GlaxoSmithKline plc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. Merck Sharp & Dohme Corp. (A subsidiary of Merck & Co., Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Novartis AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. Ache Laboratories Farmaceuticos S.A.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Bayer AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    9. boehringer ingelheim international gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    10. Cipla Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. Covis Pharma
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. Dr. Reddy’s Laboratories Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. Electromed, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. hersill
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. home oxygen company
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. horizon therapeutics plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    17. inogen, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    19. medline industries, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. Pfizer Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. Sunovion Pharmaceuticals Inc. (A Subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    22. Sun Pharmaceutical Industries Ltd.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    23. truedell medical international
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    24. Viatris Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    25. Zydus Pharmaceuticals, Inc. (A subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  20. questionnaire
  21. related reports

표 목록

TABLE 1 Europe bronchiectasis Market, pipeline analysis

TABLE 2 REGULATION imposed by several regulatory agencies in different regions

TABLE 3 Healthcare expenditure in asia-pacific

TABLE 4 THE PRICE OF X-RAY MACHINE

TABLE 5 Europe Bronchiectasis Market, By Disease Type, 2019-2028 (USD Million)

TABLE 6 Europe Non-CF Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 7 Europe CF Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 8 Europe Bronchiectasis Market, By Severity, 2019-2028 (USD Million)

TABLE 9 Europe Mild to Moderate Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 10 Europe Moderate to Severe Bronchiectasis in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 11 Europe Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 12 europe treatment in bronchiectasis Market, By Region, 2017-2028 (USD Million)

TABLE 13 Europe Treatment in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 14 Europe Treatment by Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 15 Europe Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 16 Europe Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 17 Europe Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 18 Europe Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 19 Europe Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 20 Europe Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 21 Europe Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 22 Europe Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 23 Europe Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 24 Europe Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 25 Europe Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 26 europe diagnosis in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 28 Europe Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 29 europe branded in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 30 europe generics in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 31 Europe Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 32 Europe Inhalation in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 33 Europe Oral in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 34 Europe Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 35 Europe Parenteral in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 36 Europe Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 37 Europe Bronchiectasis Market, By End User, 2019-2028 (USD Million)

TABLE 38 europe hospitals in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 39 europe clinics in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 40 europe home healthcare in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 41 europe others in bronchiectasis Market, By Region, 2019-2028 (USD Million)

TABLE 42 Europe Bronchiectasis Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 43 Europe Hospital Pharmacy in Bronchiectasis Market, region, 2019-2028 (USD Million)

TABLE 44 Europe Retail Pharmacy in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 45 Europe Online Pharmacy in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 46 Europe Others in Bronchiectasis Market, By region, 2019-2028 (USD Million)

TABLE 47 EUROPE BRONCHIECTASIS MARKET, BY REGION , 2021-2028 (USD MILLION)

TABLE 48 EUROPE BRONCHIECTASIS MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 49 Europe BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 50 Europe BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 51 Europe BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 52 Europe treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 53 Europe treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 54 Europe Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 55 Europe Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 56 Europe Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 57 Europe Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 58 Europe Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 59 Europe Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 60 Europe Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 61 Europe Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 62 Europe Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 63 Europe Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 64 Europe Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 65 Europe Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 66 Europe Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 67 Europe Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 68 Europe Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 69 Europe Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 70 Europe BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 71 Europe BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 72 GERMANY BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 73 GERMANY BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 74 GERMANY BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 75 GERMANY treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 76 GERMANY treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 77 GermanyTreatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 78 GERMANY Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 79 Germany Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 80 Germany Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 81 Germany Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 82 Germany Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 83 Germany Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 84 Germany Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 85 Germany Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 86 Germany Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 87 Germany Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 88 Germany Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 89 Germany Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 90 Germany Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 91 Germany Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 92 Germany Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 93 Germany BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 94 Germany BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 95 France BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 96 France BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 97 France BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 98 France treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 99 France treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 100 France Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 101 France Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 102 France Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 103 France Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 104 France Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 105 France Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 106 France Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 107 France Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 108 France Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 109 France Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 110 France Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 111 France Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 112 France Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 113 France Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 114 France Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 115 France Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 116 France BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 117 France BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 118 U.K. BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 119 U.K. BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 120 U.K. BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 121 U.K. treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 122 U.K. treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 123 U.K. Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 124 U.K. Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 125 U.K. Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 126 U.K. Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 127 U.K. Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 128 U.K. Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 129 U.K. Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 130 U.K. Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 131 U.K. Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 132 U.K. Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 133 U.K. Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 134 U.K. Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 135 U.K. Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 136 U.K. Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 137 U.K. Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 138 U.K. Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 139 U.K. BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 140 U.K. BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 141 Italy BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 142 Italy BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 143 Italy BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 144 Italy treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 145 Italy treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 146 Italy Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 147 Italy Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 148 Italy Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 149 Italy Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 150 Italy Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 151 Italy Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 152 Italy Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 153 Italy Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 154 Italy Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 155 Italy Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 156 Italy Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 157 Italy Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 158 Italy Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 159 Italy Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 160 Italy Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 161 Italy Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 162 Italy BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 163 Italy BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 164 Spain BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 165 Spain BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 166 Spain BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 167 Spain treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 168 Spain treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 169 Spain Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 170 Spain Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 171 Spain Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 172 Spain Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 173 Spain Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 174 Spain Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 175 Spain Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 176 Spain Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 177 Spain Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 178 Spain Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 179 Spain Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 180 Spain Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 181 Spain Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 182 Spain Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 183 Spain Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 184 Spain Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 185 Spain BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 186 Spain BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 187 Netherlands BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 188 Netherlands BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 189 Netherlands BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 190 Netherlands treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 191 Netherlands treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 192 Netherlands Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 193 Netherlands Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 194 Netherlands Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 195 Netherlands Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 196 Netherlands Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 197 Netherlands Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 198 Netherlands Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 199 Netherlands Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 200 Netherlands Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 201 Netherlands Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 202 Netherlands Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 203 Netherlands Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 204 Netherlands Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 205 Netherlands Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 206 Netherlands Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 207 Netherlands Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 208 Netherlands BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 209 Netherlands BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 210 Russia BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 211 Russia BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 212 Russia BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 213 Russia treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 214 Russia treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 215 Russia Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 216 Russia Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 217 Russia Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 218 Russia Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 219 Russia Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 220 Russia Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 221 Russia Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 222 Russia Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 223 Russia Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 224 Russia Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 225 Russia Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 226 Russia Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 227 Russia Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 228 Russia Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 229 Russia Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 230 Russia Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 231 Russia BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 232 Russia BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 233 Switzerland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 234 Switzerland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 235 Switzerland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 236 Switzerland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 237 Switzerland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 238 Switzerland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 239 Switzerland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 240 Switzerland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 241 Switzerland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 242 Switzerland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 243 Switzerland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 244 Switzerland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 245 Switzerland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 246 Switzerland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 247 Switzerland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 248 Switzerland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 249 Switzerland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 250 Switzerland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 251 Switzerland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 252 Switzerland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 253 Switzerland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 254 Switzerland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 255 Switzerland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 256 Belgium BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 257 Belgium BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 258 Belgium BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 259 Belgium treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 260 Belgium treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 261 Belgium Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 262 Belgium Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 263 Belgium Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 264 Belgium Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 265 Belgium Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 266 Belgium Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 267 Belgium Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 268 Belgium Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 269 Belgium Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 270 Belgium Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 271 Belgium Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 272 Belgium Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 273 Belgium Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 274 Belgium Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 275 Belgium Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 276 Belgium Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 277 Belgium BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 278 Belgium BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 279 Turkey BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 280 Turkey BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 281 Turkey BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 282 Turkey treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 283 Turkey treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 284 Turkey Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 285 Turkey Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 286 Turkey Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 287 Turkey Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 288 Turkey Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 289 Turkey Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 290 Turkey Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 291 Turkey Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 292 Turkey Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 293 Turkey Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 294 Turkey Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 295 Turkey Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 296 Turkey Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 297 Turkey Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 298 Turkey Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 299 Turkey Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 300 Turkey BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 301 Turkey BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 302 Austria BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 303 Austria BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 304 Austria BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 305 Austria treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 306 Austria treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 307 Austria Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 308 Austria Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 309 Austria Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 310 Austria Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 311 Austria Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 312 Austria Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 313 Austria Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 314 Austria Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 315 Austria Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 316 Austria Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 317 Austria Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 318 Austria Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 319 Austria Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 320 Austria Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 321 Austria Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 322 Austria Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 323 Austria BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 324 Austria BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 325 Norway BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 326 Norway BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 327 Norway BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 328 Norway treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 329 Norway treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 330 Norway Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 331 Norway Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 332 Norway Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 333 Norway Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 334 Norway Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 335 Norway Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 336 Norway Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 337 Norway Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 338 Norway Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 339 Norway Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 340 Norway Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 341 Norway Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 342 Norway Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 343 Norway Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 344 Norway Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 345 Norway Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 346 Norway BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 347 Norway BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 348 Hungary BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 349 Hungary BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 350 Hungary BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 351 Hungary treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 352 Hungary treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 353 Hungary Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 354 Hungary Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 355 Hungary Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 356 Hungary Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 357 Hungary Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 358 Hungary Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 359 Hungary Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 360 Hungary Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 361 Hungary Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 362 Hungary Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 363 Hungary Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 364 Hungary Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 365 Hungary Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 366 Hungary Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 367 Hungary Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 368 Hungary Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 369 Hungary BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 370 Hungary BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 371 Lithuania BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 372 Lithuania BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 373 Lithuania BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 374 Lithuania treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 375 Lithuania treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 376 Lithuania Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 377 Lithuania Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 378 Lithuania Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 379 Lithuania Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 380 Lithuania Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 381 Lithuania Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 382 Lithuania Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 383 Lithuania Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 384 Lithuania Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 385 Lithuania Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 386 Lithuania Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 387 Lithuania Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 388 Lithuania Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 389 Lithuania Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 390 Lithuania Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 391 Lithuania Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 392 Lithuania BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 393 Lithuania BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 394 Ireland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 395 Ireland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 396 Ireland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 397 Ireland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 398 Ireland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 399 Ireland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 400 Ireland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 401 Ireland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 402 Ireland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 403 Ireland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 404 Ireland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 405 Ireland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 406 Ireland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 407 Ireland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 408 Ireland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 409 Ireland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 410 Ireland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 411 Ireland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 412 Ireland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 413 Ireland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 414 Ireland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 415 Ireland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 416 Ireland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 417 Poland BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

TABLE 418 Poland BRONCHIECTASIS Market, By severity, 2019-2028 (Usd million)

TABLE 419 Poland BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 420 Poland treatment in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 421 Poland treatment by antibiotics in BRONCHIECTASIS Market, By type, 2019-2028 (USD Million)

TABLE 422 Poland Treatment by Macrolide Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 423 Poland Treatment by Cephalosporin Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 424 Poland Treatment by Aminoglycoside Antibiotics in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 425 Poland Treatment by Corticosteroids in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 426 Poland Treatment by Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 427 Poland Treatment by Long-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 428 Poland Treatment by Short-Acting Bronchodilators in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 429 Poland Treatment by Mucus Thinning Medicine in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 430 Poland Treatment by Airway Clearance Devices in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 431 Poland Treatment by Oxygen Therapy in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 432 Poland Treatment by Surgery in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 433 Poland Diagnosis in Bronchiectasis Market, By Type, 2019-2028 (USD Million)

TABLE 434 Poland Bronchiectasis Market, By Drugs Type, 2019-2028 (USD Million)

TABLE 435 Poland Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 436 Poland Oral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 437 Poland Parenteral Administration in Bronchiectasis Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 438 Poland BRONCHIECTASIS Market, By end usernel, 2019-2028 (USD Million)

TABLE 439 Poland BRONCHIECTASIS Market, By distribution channel, 2019-2028 (USD Million)

TABLE 440 rest of Europe BRONCHIECTASIS Market, By disease type, 2019-2028 (USD Million)

그림 목록

FIGURE 1 Europe BRONCHIECTASIS MARKET: SEGMENTATION

FIGURE 2 EUROPE BRONCHIECTASIS MARKET : DATA TRIANGULATION

FIGURE 3 europe Bronchiectasis Market: DROC ANALYSIS

FIGURE 4 Europe Bronchiectasis market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Bronchiectasis Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Bronchiectasis MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Bronchiectasis MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE BRONCHIECTASIS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE BRONCHIECTASIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE bronchiectasis MARKET: MARKET drugs type COVERAGE GRID

FIGURE 11 Europe Bronchiectasis market: SEGMENTATION

FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM BRONCHIECTASIS is DRIVing THE europe Bronchiectasis MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 NON-CF BRONCHIECTASIS SEGMENT is expected to account for the largest share of the europe BRONCHIECTASIS MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF EUROPE Bronchiectasis market

FIGURE 15 Number of Persons Aged 60 Years Across Several Regions in 2017 and 2050

FIGURE 16 prevalence of bronchiectasis by age in korea population (2019)

FIGURE 17 Health Spending by Major Sources of Funds

FIGURE 18 europe bronchiectasis market: BY disease type, 2021

FIGURE 19 europe bronchiectasis market: BY disease type, 2019-2028 (USD Million)

FIGURE 20 europe bronchiectasis market: BY disease type, CAGR (2021-2028)

FIGURE 21 europe bronchiectasis market: BY disease type, LIFELINE CURVE

FIGURE 22 europe bronchiectasis market: BY severity, 2021

FIGURE 23 europe bronchiectasis market: BY severity, 2019-2028 (USD Million)

FIGURE 24 europe bronchiectasis market: BY severity, CAGR(2021-2028)

FIGURE 25 europe bronchiectasis market: BY severity, LIFELINE CURVE

FIGURE 26 europe bronchiectasis market: BY type, 2021

FIGURE 27 europe bronchiectasis market: BY type, 2019-2028 (USD Million)

FIGURE 28 europe bronchiectasis market: BY type, CAGR (2021-2028)

FIGURE 29 europe bronchiectasis market: BY type, LIFELINE CURVE

FIGURE 30 europe bronchiectasis market: BY drugs type, 2021

FIGURE 31 europe bronchiectasis market: BY drugs type, 2019-2028 (USD Million)

FIGURE 32 europe bronchiectasis market: BY drugs type, CAGR (2021-2028)

FIGURE 33 europe bronchiectasis market: BY drugs type, LIFELINE CURVE

FIGURE 34 europe bronchiectasis market: BY route of administration, 2021

FIGURE 35 europe bronchiectasis market: BY route of administration, 2019-2028 (USD Million)

FIGURE 36 europe bronchiectasis market: BY route of administration, CAGR (2021-2028)

FIGURE 37 europe bronchiectasis market: BY route of administration, LIFELINE CURVE

FIGURE 38 europe bronchiectasis market: BY end user, 2021

FIGURE 39 europe bronchiectasis market: BY end user, 2019-2028 (USD Million)

FIGURE 40 europe bronchiectasis market: BY end user, CAGR (2021-2028)

FIGURE 41 europe bronchiectasis market: BY end user, LIFELINE CURVE

FIGURE 42 europe bronchiectasis market: BY distribution channel, 2021

FIGURE 43 europe bronchiectasis market: BY distribution channel, 2019-2028 (USD Million)

FIGURE 44 europe bronchiectasis market: BY distribution channel, CAGR (2021-2028)

FIGURE 45 europe bronchiectasis market: BY distribution channel, LIFELINE CURVE

FIGURE 46 EUROPE BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 47 EUROPE BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 48 EUROPE BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 49 EUROPE BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 50 EUROPE BRONCHIECTASIS market: BY Disease type (2021-2028)

FIGURE 51 Europe BRONCHIECTASIS market: SNAPSHOT (2020)

FIGURE 52 Europe BRONCHIECTASIS market: BY COUNTRY (2020)

FIGURE 53 Europe BRONCHIECTASIS market: BY COUNTRY (2021 & 2028)

FIGURE 54 Europe BRONCHIECTASIS market: BY COUNTRY (2020 & 2028)

FIGURE 55 Europe BRONCHIECTASIS market: BY Disease type (2021-2028)

FIGURE 56 Europe Bronchiectasis market: company share 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

관련 페이지 탐색

Banner